Association between medication therapy management eligibility and adherence among us renal transplant recipients

• In: Poster presentation
• At: Buenos Aires (Argentina) (2016)
• Type: Poster
• Poster code: POS-SAPS-045
• By: SPIVEY, Christina (University Of Tennessee Health Science Center, Clinical Pharmacy, Memphis, United States)
• Co-author(s): Christina Alease Spivey:Clinical Pharmacy,University Of Tennessee Health Science Center,Memphis,United States|Marie Chisholm-Burns:Clinical Pharmacy,University Of Tennessee Health Science Center,Memphis,United States|Elizabeth Tolley:Preventive Medicine,University Of Tennessee Health Science Center,Memphis,United States|Erin Kaplan:Preventive Medicine,University Of Tennessee Health Science Center,Memphis,United States
  
• Abstract:

  Medication therapy management (MTM) is a benefit of Medicare Part D available to beneficiaries who meet criteria established by the Centers for Medicare and Medicaid Services (CMS). No published studies have examined the impact of Part D MTM eligibility on renal transplant recipients’ (RTRs) immunosuppressant therapy (IST) adherence.

  Cross-sectional

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login